ArticleCureus2023

Safety of Sublingual Immunotherapy: A Secondary Analysis of Post-marketing Adverse Events Reports Using a Japanese Public Database.

Yudai Kaneda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.